DPP4 and diabetes mellitus: The use of dipeptidyl peptidase-4 (DPP-4) inhibitors was more frequent among antidiabetic medications in the three-loading group, but there were no significant differences in the baseline characteristics, such as the duration of diabetes or HbA1c level.